Femoflor® Screen test

General information:

Femoflor®Screen is a modern molecular diagnostic test for quantitative assessment of the microbiome in the female reproductive tract and diagnosis of sexually transmitted infections.

Accurate and timely diagnosis, based on the most modern molecular diagnostic technology, allows making an informed decision and a personalized approach to the treatment of the patient.

What information does the Femoflor® Screen test provide?

Quantitative assessment of the total number of microorganisms in the female urogenital tract

Quantification of the number of lactobacilli (Lactobacillus spp.)

Comparison of the amount of lactobacilli with the total number of microorganisms to assess the status and levels of the normal microflora

Quantification of anaerobic microorganisms with main etiological significance in the development of bacterial vaginosis (Gardnerella vaginalis, Prevotella bivia, Porphyromonas spp.)

Quantification of yeast-like fungi of the genus Candida

Quantification of genital mycoplasmas (Mycoplasma hominis, Ureaplasma spp.)

Detection of agents of sexually transmitted infections:

Mycoplasma genitalium

Trichomonas vaginalis

Neisseria gonorrhoeae

Chlamydia trachomatis

Herpes Simplex Virus 1

Herpes Simplex Virus 2

Cytomegalovirus

Research Guidelines:

With clinical symptoms of urogenital infections – itching, burning, increased secretion from the vagina, etc.

In chronic and repeated infections in the urogenital tract

When planning pregnancy and during pregnancy

Before upcoming surgical manipulations in the urogenital tract

In reproductive failure – repeated miscarriages and infertility

Before IVF procedures

When evaluating the effectiveness of treatment and restoration of normal microflora levels

Prevention of the condition of the microflora in the absence of symptoms

Preparation for the analysis:

Do not use a vaginal douche before the examination

It is recommended to abstain from sexual contact for at least 24-48 hours before taking the sample

It is recommended that the examination be carried out no earlier than 48 hours after colposcopy

The examination can be carried out no earlier than 10-14 days after the intake of antibacterial, antifungal medications, local antiseptics or probiotics has ended

Sample for analysis:

Vaginal + Cervical secretion

Note: In the following cases, simultaneous complex examination of both sexual partners - Femoflor®Screen (women) and Androflor®Screen (men) is recommended:

Chronic and frequently recurring infections in the urogenital tract

When clarifying the causes of infertility

When planning a pregnancy